Location History:
- Wayland, MA (US) (1999 - 2006)
- Boston, MA (US) (2017)
Company Filing History:
2 out of 3 
2 out of 818 
1 out of 1 
Years Active: 1999-2017
Title: Innovations by Inventor Rahul Ray
Introduction
Rahul Ray is an accomplished inventor based in Wayland, MA (US). He has made significant contributions to the field of cancer treatment, particularly focusing on innovative methods for targeting triple-negative breast cancer. With a total of 5 patents to his name, Ray's work exemplifies the intersection of science and technology in addressing critical health challenges.
Latest Patents
One of his latest patents is titled "Method for treating triple-negative breast cancer using AMPI-109." This patent discloses a targeted approach toward the treatment of TN breast cancer by utilizing AMPI-109, a compound known for its remarkable 'cancer-specific' characteristics. AMPI-109 demonstrates a striking capability to inhibit the proliferation of TN breast cancer cells and induce apoptosis in these cells. Notably, the growth inhibitory effect of AMPI-109 is independent of VDR. Furthermore, AMPI-109 can be combined with other oncolytic agents to enhance treatment efficacy for patients with TN breast cancer.
Another significant patent is "Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy." This invention claims an estrogen/antiestrogen-porphyrin conjugate, detailing its composition and methods for use. The active compounds consist of an estrogen or anti-estrogen portion, a tether or linker portion, and a porphyrin portion. The method exploits strong and specific interactions between the nuclear receptor and its cognate ligand, showcasing Ray's innovative approach to cancer therapy.
Career Highlights
Throughout his career, Rahul Ray has worked with notable organizations, including A&D Bioscience, Inc. and Boston University. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Ray has collaborated with esteemed colleagues such as Michael F. Holick and Scott C. Mohr. These partnerships have further enriched his research and development efforts, leading to impactful innovations in cancer treatment.
Conclusion
In summary, Rahul Ray is a pioneering inventor whose work in cancer treatment has the potential to change lives. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.